Sleep Intervention for Pediatric Epilepsy
NCT02514291 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2018-12-12
Summary
The purpose of the study is to develop and evaluate a sleep intervention program for improving sleep and health in youth with epilepsy and their parents.
Conditions
Interventions
- BEHAVIORAL
-
Sleep intervention
Standard pediatric neurology care plus education and augmented support around adequate sleep habits, appropriate daylight exposure, and beneficial and safe physical activity tailored to each epileptic child's capabilities.
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Shao-Yu Tsai, PhD · National Taiwan University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Months
- Max Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-01
- Primary Completion
- 2018-08-31
- Completion
- 2018-08-31
Countries
- Taiwan
Study Locations
More Related Trials
-
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
NCT05697614 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes
NCT05885646 ·Status: RECRUITING
-
A Pilot Study of Topiramate in Childhood Absence Epilepsy
NCT00210574 ·Status: COMPLETED ·Phase: PHASE2
-
Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children
NCT03753035 ·Status: UNKNOWN
-
Big Data Construction and Biological Etiological Epidemiology Study of Children Epilepsy in China
NCT02969213 ·Status: UNKNOWN
-
Bridging the Childhood Epilepsy Treatment Gap in Africa
NCT04290975 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children
NCT02821260 ·Status: RECRUITING
-
A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures
NCT01964560 ·Status: COMPLETED ·Phase: PHASE3
-
Minimally Invasive Surgical Epilepsy Trial for Temporal Lobe Epilepsy
NCT05019404 ·Status: UNKNOWN ·Phase: NA
-
Creation, Implementation, and Analysis of a Seizure Action Plan
NCT02995759 ·Status: COMPLETED
-
Effect of Cognitive Behavioral Play Intervention and Epilepsy
NCT06813612 ·Status: RECRUITING ·Phase: NA
-
The Efficacy of Fycompa (Perampanel) in Children With Epilepsy
NCT04608799 ·Status: COMPLETED
-
Stress and Seizures - Can a Brief Self-help Book Help?
NCT02465047 ·Status: COMPLETED ·Phase: NA
-
Adherence to Pharmacological Antiepileptic Treatment in Adolescence
NCT05825807 ·Status: UNKNOWN
-
Behavioral and Educational Tools to Improve Epilepsy Care
NCT02646631 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
NCT04625101 ·Status: COMPLETED ·Phase: PHASE2
-
Nucleotide Protein -3 in Epileptic Children
NCT04219930 ·Status: UNKNOWN
-
A Clinical Study of Children With Status Epilepticus in China
NCT03378687 ·Status: UNKNOWN
-
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
NCT05126914 ·Status: RECRUITING
-
Pediatric Epilepsy Study
NCT00050934 ·Status: COMPLETED ·Phase: PHASE3
-
Youth Epilepsy and Successful Self-Management Intervention
NCT03639233 ·Status: COMPLETED ·Phase: NA
-
A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures
NCT00292461 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy
NCT04144218 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy
NCT02911025 ·Status: COMPLETED
-
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies
NCT03650452 ·Status: COMPLETED ·Phase: PHASE2